HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma.
Li Z, Gao Q, Wu Y, Ma X, Wu F, Luan S, Chen S, Shao S, Shen Y, Zhang D, Feng F, Yuan L, Wei S.
Li Z, et al. Among authors: yuan l.
Hepatol Commun. 2024 Jan 11;8(1):e0360. doi: 10.1097/HC9.0000000000000360. eCollection 2024 Jan 1.
Hepatol Commun. 2024.
PMID: 38206204
Free PMC article.